Very late thrombosis of a drug-eluting stent deployed during primary angioplasty for ST-elevation myocardial infarction

Journal of Cardiovascular Medicine

Volumn 7, Issue 10, 2006, Pages 771-774

  Rigattieri, Stefano ^a   Patrizi, Roberto ^b   Silvestri, Pasquale ^a   Di Russo, Cristian ^a   Musto, Carmine ^a   Ferraiuolo, Giuseppe ^a   Palamara, Antonio ^a   Loschiavo, Paolo ^a  

^a SANDRO PERTINI HOSPITAL   (Italy)

^b ASL Roma B   (Italy)

Author keywords

Angioplasty; Drug eluting stents; Thrombosis

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ATENOLOL; CLOPIDOGREL; CREATINE KINASE MB; HEPARIN; PACLITAXEL; PRAVASTATIN; RAMIPRIL; TROPONIN I;

ADULT; ANAMNESIS; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR EFFECT; CARDIOVASCULAR RISK; CASE REPORT; DATA ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DRUG ELUTING STENT; DRUG HYPERSENSITIVITY; EVIDENCE BASED PRACTICE; FEMALE; HEART INFARCTION; HUMAN; IN-STENT RESTENOSIS; PATIENT MONITORING; PERCUTANEOUS CORONARY INTERVENTION; REACTION TIME; RESTENOSIS; RISK ASSESSMENT; RISK FACTOR; ST SEGMENT ELEVATION; THERAPY EFFECT; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ADULT; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ANGIOGRAPHY; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HUMANS; MYOCARDIAL INFARCTION; PACLITAXEL; RETREATMENT; RISK ASSESSMENT; THROMBECTOMY; TIME FACTORS;

EID: 33749038617     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/01.JCM.0000247326.80406.fb     Document Type: Article

References (17)

1. Babapulle MN, Joseph L, Belisle P, Brophy JM, Eisenberg MJ. A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents. Lancet 2004; 364:583-591.
2. McFadden E, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004; 364:1519-1521.
3. Cohen MG, Ohman EM. Drug-eluting stents in acute myocardial infarction: is science catching up with practice? JAMA 2005; 293:2154-2156.
4. Ong AT, McFadden EP, Regar E, de Jaegere PP, van Domburg RT, Serruys PW. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol 2005; 45:2088-2092.
5. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293:2126-2130.
6. Valgimigli M, Percoco G, Malagutti P, Campo G, Ferrari F, Barbieri D, et al., for the STRATEGY Investigators. Tirofiban and sirolimus-eluting stent vs. abciximab and bare-metal stent for acute myocardial infarction: a randomized trial. JAMA 2005; 293:2109-2117.
7. Hofma SH, Ong AT, Aoki J, van Mieghem CA, Rodriguez Granillo GA, Valgimigli M, et al. One year clinical follow up of paclitaxel eluting stents for acute myocardial infarction compared with sirolimus eluting stents. Heart 2005; 91:1176-1180.
8. Saia F, Lemos PA, Lee CH, Arampatzis CA, Hoye A, Degertekin M, et al. Sirolimus-eluting stent implantation in ST-elevation acute myocardial infarction: a clinical and angiographic study. Circulation 2003; 108:1927-1929.
9. Wong JT, Nagy CS, Krinzman SJ, Maclean JA, Bloch KJ. Rapid oral challenge-desensitization for patients with aspirin-related urticaria- angioedema. J Allergy Clin Immunol 2000; 105:997-1001.
10. Liistro F, Colombo A. Late acute thrombosis after paclitaxel eluting stent implantation. Heart 2001; 86:262-264.
11. Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 2004; 109:701-705.
12. Tanabe K, Serruys PW, Degertekin M, Grube E, Guagliumi G, Urbaszek W, et al., for the TAXUS II Study Group. Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial. Circulation 2005; 111:900-905.
13. Buffon A, Biasucci LM, Liuzzo G, D'Onofrio G, Crea F, Maseri A. Widespread coronary inflammation in unstable angina. N Engl J Med 2002; 347:5-12.
14. Mauriello A, Sangiorgi G, Fratoni S, Palmieri G, Bonanno E, Anemona L, et al. Diffuse and active inflammation occurs in both vulnerable and stable plaques of the entire coronary tree: a histopathologic study of patients dying of acute myocardial infarction. J Am Coll Cardiol 2005; 45:1585-1593.
15. Ott I. Tissue factor in acute coronary syndromes. Semin Vasc Med 2003; 3:185-192.
16. Hong MK, Mintz GS, Lee CW, Park DW, Park KM, Lee BK, et al. Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation 2006; 113:414-419.
17. Kernis SJ, Cohen D, Reid K, Bach RG, Messenger JM, Krumholz H, et al. Clinical outcomes associated with use of drug-eluting stents compared with bare-metal stents for primary percutaneous intervention [abstract]. Am J Cardiol 2005; 96 (Suppl):47H.